TickerFactsScreenerDevelopers

Aspire Biopharma Holdings, Inc. (ASBP) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2022: -$1.41M2023: -$653.1K2024: -$265.2K2025: -$4.92M-$4.92M
2022Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$4.92M-1756.6%
2024-$265.2K+59.4%
2023-$653.1K+53.6%
2022-$1.41M—